Perfusion

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here for free access to the SAGE eReference platform!

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ranucci, M.
Right arrow Articles by Brozzi, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ranucci, M.
Right arrow Articles by Brozzi, S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Perfusion, Vol. 17, No. 3, 199-204 (2002)
DOI: 10.1191/0267659102pf562oa

Different patterns of heparin resistance: therapeutic implications

Marco Ranucci

Department of Cardiothoracic Anaesthesia, Cardiovascular Centre E. Malan, University of Milan, Istituto Policlinico S. Donato, Milan, Italy, m.ranucci{at}galactica.it

Giuseppe Isgrò

Department of Cardiothoracic Anaesthesia, Cardiovascular Centre E. Malan, University of Milan, Istituto Policlinico S. Donato, Milan, Italy

Anna Cazzaniga

Department of Cardiothoracic Anaesthesia, Cardiovascular Centre E. Malan, University of Milan, Istituto Policlinico S. Donato, Milan, Italy

Antonio Ditta

Department of Cardiovascular Perfusion, Cardiovascular Centre E. Malan, University of Milan, Istituto Policlinico S. Donato, Milan, Italy

Alessandra Boncilli

Department of Cardiovascular Perfusion, Cardiovascular Centre E. Malan, University of Milan, Istituto Policlinico S. Donato, Milan, Italy

Mauro Cotza

Department of Cardiovascular Perfusion, Cardiovascular Centre E. Malan, University of Milan, Istituto Policlinico S. Donato, Milan, Italy

Giovanni Carboni

Department of Cardiovascular Perfusion, Cardiovascular Centre E. Malan, University of Milan, Istituto Policlinico S. Donato, Milan, Italy

Simonetta Brozzi

Department of Cardiovascular Perfusion, Cardiovascular Centre E. Malan, University of Milan, Istituto Policlinico S. Donato, Milan, Italy

Heparin resistance (HR) during cardiac operations is a common feature. Its aetiology often recognizes a decrease in circulating antithrombin III (AT III) due to a preoperative heparin treatment. Nevertheless, some papers highlighted the existence of HR in patients with normal values of AT III. This paper was designed in order to identify this subgroup of AT III-independent heparin-resistant patients. Five hundred consecutive patients scheduled for coronary revascularization with cardiopulmonary bypass were enrolled in this prospective trial. HR was identified in 104 (20.8%) patients. Thirty-six of them (7.2% of the total population) had a preoperative AT III activity ≥100%, and were defined as AT III-independent heparin-resistant patients. This subgroup significantly differs from the AT III-dependent heparin-resistant group being affected by a less severe degree of HR and including less patients pretreated with heparin. Unlike the other heparin-resistant patients, these subjects do not respond to AT III supplementation aimed at reaching supranormal AT III activity values.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
B. D. Spiess
Treating heparin resistance with antithrombin or fresh frozen plasma.
Ann. Thorac. Surg., June 1, 2008; 85(6): 2153 - 2160.
[Abstract] [Full Text] [PDF]


Home page
Canadian J. AnesthesiaHome page
S. Bar-Yosef, H. B. Cozart, B. Phillips-Bute, J. P. Mathew, and H. P. Grocott
Preoperative low molecular weight heparin reduces heparin responsiveness during cardiac surgery: [L'heparine de bas poids moleculaire en preoperatoire reduit la reponse a l'heparine pendant la chirurgie cardiaque]
Can J Anesth, February 1, 2007; 54(2): 107 - 113.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
H. Pleym, V. Videm, A. Wahba, A. Asberg, T. Amundsen, L. Bjella, O. Dale, and R. Stenseth
Heparin resistance and increased platelet activation in coronary surgery patients treated with enoxaparin preoperatively.
Eur. J. Cardiothorac. Surg., June 1, 2006; 29(6): 933 - 940.
[Abstract] [Full Text] [PDF]


Home page
PerfusionHome page
M. Ranucci, A. Ditta, A. Boncilli, M. Cotza, G. Carboni, S. Brozzi, C. Bonifazi, and A. Tiezzi
Determinants of antithrombin consumption in cardiac operations requiring cardiopulmonary bypass
Perfusion, January 1, 2004; 19(1): 47 - 52.
[Abstract] [PDF]